London Breast Institute
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
May, 2024
May 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Apr
London Breast Institute
Apr 28, 2024, 23:57 |
Blog
Kefah Mokbel summarizes estrogen-alone use and breast cancer incidence by Rowan T. Chlebowski et al
Kefah Mokbel, Chair of The Multidisciplinary Breast Cancer Program at London Breast Institute, shared on…
Apr 21, 2024, 18:10 |
Insight
Kefah Mokbel: Young onset breast cancer with germline BRCA Pathogenic Variants was associated with increased risk for all-cause mortality if diagnosed within 10 years after last childbirth
Apr 3, 2024, 13:35 |
Insight
Kefah Mokbel: Insights into the management of Leptomeningeal Disease and clinical outcomes
Kefah Mokbel, Chair of The Multidisciplinary Breast Cancer Program at London Breast Institute, shared on…
All:
3
Posts:
1 - 10
10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors - 2024 edition by OncoDaily
Elie G. Dib: Excited to share the results of the TAPUR study
OncoInfluencers: Dialogue with Fadlo R. Khuri, hosted by Gevorg Tamamyan
Cedars-Sinai is co-chairing a special AACR conference on transforming the field of Bladder Cancer on May 17-20
Barbara Jereczek-Fossa has been elected as the ESTRO President-elect!
Facebook
RSS Feed
Twitter
Linkedin
Youtube